Create personalized user journeys with Omnichannel Marketing as a Service.
Empower your marketing operations with AI and Data.
Adopt a future-proof holistic approach to content strategy.
Leverage a suite of professional services for pharma and life sciences.
Develop and enable adaptable pharma and life sciences marketing content.
Enable format-free marketing with content management platform.
Your AI-Powered Congress Engagement Coordinator – Connect Easily, Stay Compliant, and Follow Up Smarter
Discover our story, values, and how we're making a positive impact
Explore the heart of our organization and meet the visionary minds
The Viseven team is about respect, diversity, comfortable working conditions, and equal opportunities for everyone. We explore, evolve, and adapt – together.
We have exciting news to share! Our team is heading to the Collision conference in Toronto, Canada on June 20-23. What’s more exciting? Viseven CEO – Nataliya Andreychuk will be a keynote speaker at HealthConf on June 23 addressing the attendees at 10:30 AM EDT. As some of you may know the war in Ukraine […]
Are you looking to find out more about modular content? Do you want to know the latest insights into metadata and tagging? Then our second session of the Modular Content Lab series is the right webinar for you. The Metadata Excellence and Tagging session on June 8 at 12 PM EST / 9 AM PST […]
Viseven is heading to Chicago for the No Code Days: Freedom to Create conference organized by Creatio. The free 2-day conference will connect hundreds of professionals. The event is dedicated to implementing no-code solutions for business units wired to the technical industries. The two-day conference will highlight the best practices for international digital business needs. […]
Can isolation and innovation work together? We proved; we can make it. As they say, however, two masterminds always act better, turning any challenge into balance. Thus, Next Pharma got us together again around the industry’s sharpest commercial event. On May 17-18, Dubrovnik turned into the center of decision-making on what is next for pharma. At […]
Modular content has been in the spotlight of many discussions in the pharma marketing community lately. Not only is it said to deliver the industry from chronic “ailments” like MLR hurdles, content production bottlenecks, and time-to-market anxieties – there are rumors this approach is capable of much more. Fueling omnichannel ambitions with personalized content […]
Veeva Summit once again proved that communication, in fact, is the language of leadership. On May 5, all life sciences industry leaders were invited to Boston to meet the lineup of the best industry experts in the pharma and tech fields. At 55+ sessions, they are about to share the latest findings, valuable insights and […]
Why is a raven like a writing desk? Who knows! However, we know exactly what is common between tech and art. Both are products of human imagination. Being the complicated area where many things come together and overlap, the content creation in pharma is a palette of different systems and tools mixed with the strategic work of […]
As the year comes to a close, we often take a moment to reflect on the past 12 months and the lessons they brought. While some look back on everything that has happened, others focus on what the future may hold. How should we move in the year to come? What does 2026 have in […]
The latest eWizard release focuses on the marketers’ pain points that don’t get enough attention in life sciences. They sit in everyday workflows, hidden in plain sight, and the status quo keeps them there. So, we decided to challenge that. This update brings improvements that make agentic AI a practical choice for compliant content creation, simplify the roll-out of modular content in life sciences, reduce the heavy dependence on creative agencies, and help […]
A marketing asset is ready for launch, but gets stuck in review. Legal raises concerns, medical edits again, and the latest version is buried in a chain of emails. The deadline is slipping, and no one’s certain what’s approved. Scenes like this are common in pharma, where compliance touches every part of content, communication, and […]
